About Sparsh Bio-Tech Private Limited
Data last updated:
Sparsh Bio-Tech Private Limited is a private limited company based in Jamnagar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2001PTC039373. Its GSTIN is 24AAFCS5556F1ZC (Gujarat).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.35 Cr. It is led by directors including Ashok Juthalal Maru (Managing Director) and Sundeep Premchand Maru (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Jamnagar, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹346.49 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹11.45 Cr (net margin 3.3%) and EBITDA of ₹21.65 Cr (EBITDA margin 6.2%).
The company has about 202 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sparsh bio-tech. As per MCA filings, the company has open charges of ₹25.79 Cr and satisfied charges of ₹3.05 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 1 case is pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹1.04 Cr; the latest was in February 2012. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Mepro Pharmaceuticals Private Limited with revenue of ₹356.46 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2020, listing 634 overdue payments to 22 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sparshbiotech.com.
Company details
Contact details
Sparsh Bio-Tech Private Limited's registered office is in Jamnagar, Gujarat. Its website is sparshbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.1 Survey No. 242/243/244 Village Lakhabavad Post Khodiyar Colon, Y, Jamnagar, Gujarat, India – 361006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sparsh Bio-Tech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sparsh Bio-Tech operates one associated brand: Sparsh bio-tech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceuticals, focusing on dosage forms like capsules and tablets. | sparshbiotech.com |
Business activity
The main business activity of Sparsh Bio-Tech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sparsh Bio-Tech Private Limited, buy the company report.
Financials of Sparsh Bio-Tech Private Limited
FY 2024 filings availableSparsh Bio-Tech Private Limited reported revenue of ₹346.49 Cr (down 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year. EBITDA fell 45% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.65 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.45 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sparsh Bio-Tech Private Limited, buy the company report.
Board of directors of Sparsh Bio-Tech Private Limited
Sparsh Bio-Tech has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rasik Hirji Haria Also directs: Aparaa Industries Private Limited, Trentium Lifesciences Private Limited, Sevenclaps Export Private Limited and 1 more | Director | 03 Nov 2001 | 24 Years 11 Months | Current |
| Ashok Juthalal Maru | Managing Director | 30 Mar 2001 | 25 Years 6 Months | Current |
| Sundeep Premchand Maru | Whole-Time Director | 30 Sep 2005 | 21 Years 0 Months | Current |
| Paras Juthalal Maru | Whole-Time Director | 01 Apr 2003 | 23 Years 6 Months | Current |
Peer comparison
Sparsh Bio-Tech Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mepro Pharmaceuticals Private Limited | ₹356.46 Cr (FY 2025) | 20.0% | Surendra Nagar, Gujarat, India | |||
| Bharat Parenterals Limited | ₹352 Cr (FY 2025) | 32.0% | Vadodara, Gujarat, India | |||
| Geno Pharmaceuticals Private Limited | ₹349.47 Cr (FY 2025) | 14.0% | Goa, India | |||
| Sparsh Bio-Tech Private Limitedthis company | ₹346.49 Cr (FY 2025) | ₹11.45 Cr | 3.3% | -29.0% | 202 | Jamnagar, Gujarat, India |
| Capsugel Healthcare Private Limited | ₹340.69 Cr (FY 2025) | 9.0% | Gurugram, Haryana, India | |||
| Walter Bushnell Enterprises Private Limited | ₹340.47 Cr (FY 2025) | 132.0% | Mumbai, Maharashtra, India | |||
| Ozone Pharmaceuticals Limited | ₹337.45 Cr (FY 2025) | -1.0% | New Delhi, Delhi, India | |||
| Titan Laboratories Private Limited | ₹332.25 Cr (FY 2025) | 22.0% | Mumbai, Maharashtra, India | |||
| Sainor Laboratories Private Limited | ₹328.35 Cr (FY 2025) | -34.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sparsh Bio-Tech Private Limited, buy the company report.
Auditor
Sparsh Bio-Tech Private Limited is audited by SARDA & SARDA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARDA & SARDA | FY 2024 | 109264W |
Shareholding
The shareholding of Sparsh Bio-Tech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sparsh Bio-Tech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jun 2020 | 100340550 | Axis Bank Limited | ₹49 Lakh | Open | |
| 30 May 2008 | 10113511 | Others | ₹25.3 Cr | Open | |
| 17 Dec 2002 | 90104183 | Oriental Bank of Commerce | ₹63.04 Lakh | Satisfied | |
| 17 Dec 2002 | 90105875 | Oriental Bank of Commerce | ₹1.17 Cr | Satisfied | |
| 17 Dec 2002 | 90106687 | Oriental Bank of Commerce | ₹1.25 Cr | Satisfied |
To see the full charge records of Sparsh Bio-Tech Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Sparsh Bio-Tech Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹1.04 Cr; the latest was in February 2012.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2012 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Jan 2010 | Funding round | ₹1.04 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sparsh Bio-Tech Private Limited has 6 court cases on record: 5 filed by Sparsh Bio-Tech, 1 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 0 |
| High courts | 2 | 0 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Execution petition | Filed by the company against Aglowmed Limited | Disposed |
| District court, Jamnagar, Gujarat | Court case (SMST R) | Filed by the company against Aglowmed Ltd. | Disposed |
| District court, Jamnagar, Gujarat | Court case (SMST S) | Filed by the company against Aglowmed Limited | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against State of Gujarat and 1 other | Pending |
| District court, Ahmedabad, Gujarat | Court case (SPCS COMP) | Filed against the company by The Registrar of Companies | Disposed |
To see the full case history of Sparsh Bio-Tech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sparsh Bio-Tech Private Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 634 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Alpa Laboratories Limited | |||
| an individual supplier | |||
| Satellite Polypack Industries | |||
| Rajat Vinyls Private Limited |
To see the full MSME payment records of Sparsh Bio-Tech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sparsh Bio-Tech Private Limited has a workforce of 202 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Sparsh Bio-Tech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCS5556F1ZC | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sparsh Bio-Tech Private Limited, buy the company report.
Recent activity
Sparsh Bio-Tech Private Limited has 6 board changes on record since 2001: 4 appointments and 2 cessations. The latest: Sundeep Premchand Maru ceased to be Director on 01 Apr 2014.
8 earlier events are in the company report.
Frequently asked questions
Sparsh Bio-Tech is an active private limited company based in Jamnagar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 2001 (25+ years old) and is registered under CIN U24231GJ2001PTC039373.
Sparsh Bio-Tech has 4 current directors:
- Ashok Juthalal Maru - Managing Director
- Sundeep Premchand Maru - Whole-Time Director
- Paras Juthalal Maru - Whole-Time Director
- Rasik Hirji Haria - Director
The latest financial statements of Sparsh Bio-Tech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sparsh Bio-Tech is 24AAFCS5556F1ZC, registered in Gujarat.
The CIN (Corporate Identification Number) of Sparsh Bio-Tech is U24231GJ2001PTC039373. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sparsh Bio-Tech has 6 court cases on record: 5 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Sparsh Bio-Tech was incorporated on 30 March 2001, making it 25+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Sparsh Bio-Tech has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹1.04 Cr; the latest was in February 2012.
The peers of Sparsh Bio-Tech by revenue are Mepro Pharmaceuticals Private Limited, Bharat Parenterals Limited, Geno Pharmaceuticals Private Limited, Capsugel Healthcare Private Limited, Walter Bushnell Enterprises Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sundeep Premchand Maru ceased to be Director on 01 Apr 2014. Paras Juthalal Maru ceased to be Whole-Time Director on 01 Apr 2006. Sundeep Premchand Maru was appointed as Whole-Time Director on 30 Sep 2005. Sparsh Bio-Tech has 6 board changes on record in total.
Sparsh Bio-Tech has 4 MSME Form 1 returns on record between 2019 and 2020, listing 634 overdue payments to 22 micro and small suppliers. The latest return was filed on 01 Oct 2020.
Sparsh Bio-Tech can be reached through the website sparshbiotech.com. Its registered office is in Jamnagar, Gujarat, India.